Elevated EREG expression in the tumor microenvironment, particularly from fibroblasts and macrophages, activates EGFR signaling through autocrine and paracrine loops, enhancing fibroblast migration and contributing to therapeutic resistance in CC (Yoshida 2020; Luraghi et al. 2014). The gene discussed is EGFR; the disease is neoplasm.